Financial News
All News about Catalent Inc
![](https://cdn.benzinga.com/files/images/story/2024/06/21/pharma-lab-worker-ai.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/05/Stock-HealthCloud-01-adobe.jpg)
![](https://mms.businesswire.com/media/20240529233385/en/772236/22/Catalent_CMYK.jpg)
From Catalent, Inc.
Via Business Wire
![](https://g.foolcdn.com/editorial/images/778632/individual-investor-devices-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Beyond The Numbers: 6 Analysts Discuss Catalent Stock
April 04, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
(CTLT) - Analyzing Catalent's Short Interest
February 28, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
In-Depth Examination Of 5 Analyst Recommendations For Catalent
February 20, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/24/Hedge-Funds-Photo-by-Panchenko-Vladimir-.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2023/05/ctlt1600.png)
![](https://mms.businesswire.com/media/20240507163487/en/772236/22/Catalent_CMYK.jpg)
From Catalent, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2024/05/02/Ozempic-and-other-drugs-for-weight-loss.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240417817414/en/805853/22/Robbins_LLP.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Wegovy_11.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
![](https://g.foolcdn.com/editorial/images/770468/ozempic.jpg)
Via Talk Markets
![](https://g.foolcdn.com/editorial/images/769494/medicine-pills-fda-approval-stamp.jpg)
![](https://investorplace.com/wp-content/uploads/2022/08/pharmaceutical1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/Ozempic-maker-Novo-Nordisk_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240307376172/en/772236/22/Catalent_CMYK.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/mounjaro-medication-for-weight-loss_7.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/767512/statistic_id271464_diabetics-prevalence-worldwide-2021-2030-and-2045.png)
![](https://cdn.benzinga.com/files/images/story/2024/SP500.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/Wall-Street_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/weight-loss-shutter2.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240216824700/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240215083237_sp-500s-surge-to-new-highs-bull-trap-hiding-in-pla.jpg)
S&P 500's surge to new highs: Bull trap hiding in plain sight?
February 15, 2024
Via MarketBeat
![](https://cdn.benzinga.com/files/images/story/2024/SP500-Shutterstock.jpeg?width=1200&height=800&fit=crop)
Nearly Half Of S&P 500 Stocks Trade Below 50-Day Moving Average: Which One Is The Cheapest?
February 14, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.